Patient-reported outcomes of rimegepant for acute and preventive treatment of migraine in China: a prospective, multicenter, real-world study.

J Headache Pain · 2025 · PMC12595842 · PMID 41204073

Europe PMC DOI

hedged sentence

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

did not reach statistical significanceP = 0.069so close (0.05 < p ≤ 0.1)

The PT group showed a comparable numerical improvement from 40.9 (18.1) at baseline to 52.4 (23.2) post-treatment (mean change 11.4; 95% CI: -0.8, 23.6), though this did not reach statistical significance ( P = 0.069).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.